Elicio Therapeutics Inc.
ELTX
We are a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mutant Kirsten rat sarcoma viral oncogene homolog ( mKRAS ) - positive pancreatic cancer, colorectal cancer ( CRC ), lung cancer and other mKRAS positive cancers. We intend to build on recent clinical successes in the personalized cancer immunotherapy space to develop ef…
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$36M
▲ +23.8% YoY
Op. Margin
–
ROIC
-141.79%
▲ +19.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$37M
▲ +0.5% YoY
Op. Cash Flow (TTM)
-$37M
▲ +0.3% YoY
Net Debt
-$17M
Net Cash Position
Cash & Equiv.
$31M
Continue Research
Peers
Pharmaceutical Preparations · Pick stocks to compare with ELTX
Elicio Therapeutics (ELTX) in three numbers
Questions about Elicio Therapeutics
Is Elicio Therapeutics a high-quality business?
Elicio Therapeutics scores 25 out of 100 on Intrinsiqq's quality score, which makes it a lower-quality business on these measures. The score blends 6 checks computed from SEC filings. Its best check is margin trend at +887.8pp, and its weakest is return on capital at -141.8%. The Quality tab shows every check against its target.
Does Elicio Therapeutics (ELTX) pay a dividend?
No. Elicio Therapeutics (ELTX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.
Source: 10-Q filed 3 Nov 2026 (period ending 30 Sept 2026), SEC. Price: last close 20 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.
Spot a number that looks wrong? Check it in ELTX's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ELTX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.